INIA Biosciences Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
14
INIA Biosciences General Information
Description
Developer of a noninvasive, closed-loop, home-use monitoring system intended to treat and prevent organ failure. The company's system integrates biomarker monitoring with an ultrasound stimulator to reduce the inflammation implicated in transplant rejection rates and dependence on immunosuppressant drugs, enabling physicians to avail novel diagnostic sensing to treat chronic diseases.
Contact Information
Website
www.iniabiosciences.comCorporate Office
- 100 Morrissey Boulevard
- Boston, MA 02125
- United States
Corporate Office
- 100 Morrissey Boulevard
- Boston, MA 02125
- United States
INIA Biosciences Timeline
INIA Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 14. Early Stage VC | 25-Sep-2024 | Completed | Generating Revenue | |||
| 13. Grant | 13-Mar-2024 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 11. Grant | 02-Oct-2023 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 29-Sep-2022 | Completed | Generating Revenue | |||
| 9. Grant | 09-Apr-2022 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 22-Mar-2022 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 24-Dec-2021 | Completed | Generating Revenue |
INIA Biosciences Patents
INIA Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4463225-A1 | Wearable ultrasound device and harness for immunomodulation, and uses thereof | Pending | 13-Jan-2022 | ||
| EP-4463225-A4 | Wearable ultrasound device and harness for immunomodulation, and uses thereof | Pending | 13-Jan-2022 | ||
| US-12758799-B2 | Wearable ultrasound device and harness for immunomodulation, and uses thereof | Active | 13-Jan-2022 | ||
| US-20250073503-A1 | Wearable ultrasound device and harness for immunomodulation, and uses thereof | Active | 13-Jan-2022 | ||
| WO-2023137368-A1 | Wearable ultrasound device and harness for immunomodulation, and uses thereof | Inactive | 13-Jan-2022 | A61N7/00 |
INIA Biosciences Signals
INIA Biosciences Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioInnovation Institute | Accelerator/Incubator | |||
| Ankh Impact Ventures | Venture Capital | Minority | ||
| US National Science Foundation | Accelerator/Incubator | |||
| MedTech Innovator | Accelerator/Incubator | |||
| ASU Innovation Open | University |
INIA Biosciences FAQs
-
When was INIA Biosciences founded?
INIA Biosciences was founded in 2020.
-
Where is INIA Biosciences headquartered?
INIA Biosciences is headquartered in Boston, MA.
-
What is the size of INIA Biosciences?
INIA Biosciences has 5 total employees.
-
What industry is INIA Biosciences in?
INIA Biosciences’s primary industry is Monitoring Equipment.
-
Is INIA Biosciences a private or public company?
INIA Biosciences is a Private company.
-
What is INIA Biosciences’s current revenue?
The current revenue for INIA Biosciences is .
-
How much funding has INIA Biosciences raised over time?
INIA Biosciences has raised $200K.
-
Who are INIA Biosciences’s investors?
BioInnovation Institute, Ankh Impact Ventures, US National Science Foundation, MedTech Innovator, and ASU Innovation Open are 5 of 14 investors who have invested in INIA Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process